01 6Propecia
02 3Proscar
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 136
2020 Revenue in Millions : 129
Growth (%) : 5
Main Therapeutic Indication : Dermatology
Currency : USD
2021 Revenue in Millions : 117
2020 Revenue in Millions : 176
Growth (%) : -34
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 101
2021 Revenue in Millions : 117
Growth (%) : -14
Main Therapeutic Indication : Dermatology
Currency : USD
2022 Revenue in Millions : 125
2021 Revenue in Millions : 136
Growth (%) : -8
Main Therapeutic Indication : Dermatology
Currency : USD
2023 Revenue in Millions : 125
2022 Revenue in Millions : 125
Growth (%) : 0
Main Therapeutic Indication : Dermatology
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 101
Growth (%) : -4
Main Therapeutic Indication : Others
Currency : USD
2015 Revenue in Millions : 264
2014 Revenue in Millions : 183
Growth (%) : -31%
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : -6.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Dermatology
Currency : USD
2016 Revenue in Millions : Not Reported
2015 Revenue in Millions : 183
Growth (%) : -100
LOOKING FOR A SUPPLIER?